CurvaFix, Inc.
PrivateLast Round
Series C
Jul 14, 2023
Total Funding Raised
$63.42M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CurvaFix, Inc. operates in Healthcare & Life Sciences and is based in Bellevue, Washington. Its latest recorded funding round was a Series C round in July 2023.
CurvaFix, Inc. is a medical device company that develops implantable solutions tailored to address unmet needs in pelvic trauma, allowing for minimally invasive surgeries and promoting faster patient recovery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CurvaFix, Inc. Comparables
Compare CurvaFix, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| I.T.S. GmbH | 78% | |
| Stryker Corporation | 74% | |
| Citieffe | 71% |
For institutional investors. Book with your work email.
CurvaFix, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 14, 2023 | ||||
| Series B | Jul 21, 2020 | ||||
| Series A | Jun 7, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CurvaFix, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Seed |
| Genome British Columbia | Seed |
| Tech Coast Angels | Series A, Series C |
| Keiretsu Capital | Series A, Series C |
| SWAN Venture Fund | Series A, Series C |
| Sectoral | Series C, Series B |
| TCA Venture Group | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 93% MoM.
- Apr 20, 2026
Monthly visitors increased 214% MoM, reaching 2.6K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 17, 2026
CurvaFix, Inc. is scheduled to sponsor an industry session and exhibit at the 42nd Annual Orthopaedic Trauma Association Meeting in Tennessee on Sep 23rd-26th '26, where orthopedic trauma surgeons present real-world performance data from the first 3,800 CurvaFix implants.
For institutional investors. Book with your work email.
CurvaFix, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CurvaFix, Inc.'s valuation, stock price, and market status.
Is CurvaFix, Inc. a public or private company?
CurvaFix, Inc. is a private company.
What is the current stock price of CurvaFix, Inc.?
CurvaFix, Inc. is a private company, so its shares have no public market price. Caplight tracks CurvaFix, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CurvaFix, Inc. worth (valuation)?
Valuation information for CurvaFix, Inc. is not publicly available.
Can I buy CurvaFix, Inc. stock?
CurvaFix, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CurvaFix, Inc.'s last funding round?
CurvaFix, Inc.'s most recent funding round was Series C on July 14, 2023.
Who are the main investors in CurvaFix, Inc.?
Key investors in CurvaFix, Inc. include Sectoral, MVM Life Science Partners LLP.
Will CurvaFix, Inc. IPO soon?
No public IPO plans have been announced for CurvaFix, Inc..
How can I track CurvaFix, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in CurvaFix, Inc.'s shares on secondary markets.